You are here

  • Home
  • Archive
  • Volume 99, Issue Suppl 1
  • PFM.08 Ethics and ethical evaluation of a proposed clinical trial with maternal uterine artery vascular endothelial growth factor gene therapy to treat severe early-onset fetal growth restriction in pregnant women

Article info

Article menu
Download PDFPDF
Poster presentations
BMFMS: Fetal Medicine
PFM.08 Ethics and ethical evaluation of a proposed clinical trial with maternal uterine artery vascular endothelial growth factor gene therapy to treat severe early-onset fetal growth restriction in pregnant women

Authors

Citation

Sheppard M, David A, Spencer R, et al
PFM.08 Ethics and ethical evaluation of a proposed clinical trial with maternal uterine artery vascular endothelial growth factor gene therapy to treat severe early-onset fetal growth restriction in pregnant women
Archives of Disease in Childhood - Fetal and Neonatal Edition 2014;99:A85.

Publication history

  • First published June 9, 2014.
Online issue publication 
October 26, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2014, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions